The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization

Cancer Res. 2011 Jan 15;71(2):371-82. doi: 10.1158/0008-5472.CAN-10-3221. Epub 2010 Dec 2.

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder associated mainly with tumors of multiple endocrine organs. Mutations in the MEN1 gene that encodes for the menin protein are the predominant cause for hereditary MEN1 syndrome. Though menin is a tumor suppressor, its molecular mechanism of action has not been defined. Here, we report that menin interacts with AKT1 in vitro and in vivo. Menin downregulates the level of active AKT and its kinase activity. Through interaction with AKT1, menin suppresses both AKT1-induced proliferation and antiapoptosis in nonendocrine and endocrine cells. Confocal microscopy analysis revealed that menin regulates AKT1 in part by reducing the translocation of AKT1 from the cytoplasm to the plasma membrane during growth factor stimulation. Our findings may be generalizable to other cancers, insofar as we found that loss of menin expression was also associated with AKT activation in a mouse model of pancreatic islet adenoma. Together, our results suggest menin as an important novel negative regulator of AKT kinase activity.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adenoma, Islet Cell / metabolism
  • Animals
  • Cell Growth Processes
  • Cell Membrane / enzymology
  • Cell Membrane / metabolism
  • Enzyme Activation
  • HEK293 Cells
  • Humans
  • Mice
  • Microscopy, Confocal
  • Pancreatic Neoplasms / metabolism
  • Proto-Oncogene Proteins / deficiency
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Transfection

Substances

  • MEN1 protein, human
  • Men1 protein, mouse
  • Proto-Oncogene Proteins
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt